News & Events

Recent News View All News

Feb 2, 2023 4:05pm EST

Rigel Announces Publication of REZLIDHIA™ (olutasidenib) Phase 2 Clinical Results in Blood Advances

Jan 18, 2023 8:05am EST

National Comprehensive Cancer Network® Adds Newly Approved REZLIDHIA™ (olutasidenib) to Clinical Practice Guidelines in Oncology for Acute Myeloid Leukemia

View All News

Corporate Presentation

January 2023

Recent Events View All Events

Dec 10 – Dec 13, 2022

American Society of Hematology Annual Meeting and Exposition

View IR Calendar